Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.

Diamond JR.

Kidney Int Suppl. 1991 Apr;31:S29-34. Review.

PMID:
2046267
3.

Lipids and the progression of renal disease.

Keane WF, O'Donnell MP, Kasiske BL, Schmitz PG.

J Am Soc Nephrol. 1990 Nov;1(5 Suppl 2):S69-74. Review.

PMID:
16989069
4.

Hyperlipidemia and glomerular sclerosis: an alternative viewpoint.

Anderson S, King AJ, Brenner BM.

Am J Med. 1989 Nov;87(5N):34N-38N. Review.

PMID:
2486544
5.

Hyperlipidemia of nephrosis: pathophysiologic role in progressive glomerular disease.

Diamond JR.

Am J Med. 1989 Nov;87(5N):25N-29N. Review.

PMID:
2486541
6.

The role of reactive oxygen species in animal models of glomerular disease.

Diamond JR.

Am J Kidney Dis. 1992 Mar;19(3):292-300. Review.

PMID:
1553976
7.

Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis.

Rennke HG, Klein PS.

Am J Kidney Dis. 1989 Jun;13(6):443-56. Review.

PMID:
2658558
8.

Pathobiology of focal sclerosis.

Wolthuis A, van Goor H, Weening JJ, Grond J.

Curr Opin Nephrol Hypertens. 1993 May;2(3):458-64. Review.

PMID:
7922206
9.

A putative role of hypercholesterolemia in progressive glomerular injury.

Diamond JR, Karnovsky MJ.

Annu Rev Med. 1992;43:83-92. Review.

PMID:
1580608
10.

The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.

Schwartz MM.

Ren Fail. 2000 Nov;22(6):663-84. Review.

PMID:
11104157
11.

Glomerulosclerosis, arteriosclerosis, and vascular graft stenosis: treatment with oral heparinoids.

Striker GE, Lupia E, Elliot S, Zheng F, McQuinn C, Blagg C, Selim S, Vilar J, Striker LJ.

Kidney Int Suppl. 1997 Dec;63:S120-3. Review.

PMID:
9407438
12.

Hyperlipidemia and the progression of renal disease.

Keane WF, Kasiske BL, O'Donnell MP.

Am J Clin Nutr. 1988 Jan;47(1):157-60. Review.

PMID:
3276133
13.

Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?

Smeets B, Dijkman HB, Wetzels JF, Steenbergen EJ.

J Pathol. 2006 Nov;210(3):263-72. Review.

PMID:
16924588
14.

Mechanisms of hypertensive glomerular injury.

Tolins JP, Shultz P, Raij L.

Am J Cardiol. 1988 Oct 5;62(11):54G-58G. Review.

PMID:
3051996
15.

Mechanisms of disease: focal segmental glomerulosclerosis.

Meyrier A.

Nat Clin Pract Nephrol. 2005 Nov;1(1):44-54. Review.

PMID:
16932363
16.

Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis.

Haller H.

Am J Kidney Dis. 1993 Jun;21(6 Suppl 3):26-31. Review.

PMID:
8503431
17.

Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.

Elema JD, Weening JJ, Grond J.

Contrib Nephrol. 1988;60:73-82. Review. No abstract available.

PMID:
3278860
18.

Renal protective effects of angiotensin-converting enzyme inhibition.

Keane WF, Shapiro BE.

Am J Cardiol. 1990 May 22;65(19):49I-53I. Review.

PMID:
2186611
19.

Focal and segmental glomerulosclerosis: analogies to atherosclerosis.

Diamond JR, Karnovsky MJ.

Kidney Int. 1988 May;33(5):917-24. Review.

Items per page

Supplemental Content

Write to the Help Desk